Evidence map›Paper›PMID 36901942›Full record

ArticleInternational journal of molecular sciences2023

General Trends of the

Akhila Melarkode Vattekatte, Julien Diharce, Joseph Rebehmed, Frédéric Cadet, Fabrice Gardebien, Catherine Etchebest, Alexandre G de Brevern

Full text read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Evaluation of the Potential Impact of In Silico Humanization on VInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Akhila Melarkode VattekatteUniversité de Paris, INSERM, BIGR, F-75014 Paris, France.ORCID 0000-0002-4302-7030
Julien DiharceUniversité de Paris, INSERM, BIGR, F-75014 Paris, France.
Joseph RebehmedDepartment of Computer Science and Mathematics, Lebanese American University, Beirut 1102 2801, Lebanon.ORCID 0000-0002-0909-6155
Frédéric CadetUniversité de la Réunion, INSERM, BIGR, F-97715 Saint-Denis, France.
Fabrice GardebienUniversité de la Réunion, INSERM, BIGR, F-97715 Saint-Denis, France.
Catherine EtchebestUniversité de Paris, INSERM, BIGR, F-75014 Paris, France.
Alexandre G de BrevernUniversité de Paris, INSERM, BIGR, F-75014 Paris, France.ORCID 0000-0001-7112-5626

Funding

Agence Nationale de la Recherche ANR-11-IDEX-0005-02Agence Nationale de la Recherche ANR-11-LABX-0051Agence Nationale de la Recherche ANR-18-IDEX-0001Agence Nationale de la Recherche ANR-19-CE17-0021Indo-French Centre for the Promotion of Advanced Research 5302-2National Computer Center for Higher Education A0040710426National Computer Center for Higher Education A0110713032PHC CEDRE 47811WMPOE FEDER 2014-20 of the Conseil Régional de La Réunion - EU-H2020 and Université de la Réunion S3D VHH program, N° SYNERGIE RE0022962
6 · The paper itself

Abstract

Conformational flexibility plays an essential role in antibodies' functional and structural stability. They facilitate and determine the strength of antigen-antibody interactions. Camelidae express an interesting subtype of single-chain antibody, named Heavy Chain only Antibody. They have only one N-terminal Variable domain (V

Indexed as

CamelidaeImmunoglobulin Variable RegionAnimalsComplementarity Determining RegionsImmunoglobulin Heavy ChainsMolecular Dynamics SimulationComplementarity Determining RegionsImmunoglobulin Heavy ChainsImmunoglobulin Variable Regionantibodydisorderflexibilitymobilitymolecular dynamics simulationnanobodyProtein Blockssingle-chain antibodystructural alphabetsybody

Identifiers

PMID36901942
PMCPMC10003728

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read43
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.